Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Yates LM"'
Publikováno v:
BJOG: An International Journal of Obstetrics & Gynaecology; Jun2014, Vol. 121 Issue 7, p901-906, 6p, 1 Chart
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bluett-Duncan M; Division of Neuroscience, University of Manchester, Manchester, UK., Bullen P; Department of Obstetric and Fetal Medicine, St. Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester, UK., Campbell E; Department of Neurology, Belfast Health and Social Care Trust, Belfast, UK., Clayton-Smith J; Manchester Centre for Genomic Medicine, St. Mary's Hospital, University of Manchester, Manchester, UK.; Division of Evolution and Genomic Sciences, School of Biological Sciences, University of Manchester, Manchester, UK., Craig J; Department of Neurology, Belfast Health and Social Care Trust, Belfast, UK., García-Fiñana M; Department of Health Data Science, Institute of Population Health, University of Liverpool, Liverpool, UK., Hughes DM; Department of Health Data Science, Institute of Population Health, University of Liverpool, Liverpool, UK., Ingham A; Manchester Centre for Genomic Medicine, St. Mary's Hospital, University of Manchester, Manchester, UK., Irwin B; Department of Neurology, Belfast Health and Social Care Trust, Belfast, UK., Jackson C; Department of Neuropsychology, Walton Centre for Neurology and Neurosurgery NHS Foundation Trust, Liverpool, UK., Kelly T; Department of Obstetric and Fetal Medicine, St. Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester, UK., Morrow J; Department of Neurology, Belfast Health and Social Care Trust, Belfast, UK., Rushton S; Manchester Centre for Genomic Medicine, St. Mary's Hospital, University of Manchester, Manchester, UK., Winterbottom J; Department of Neurology, Walton Centre for Neurology and Neurosurgery NHS Foundation Trust, Liverpool, UK., Wood AG; School of Psychology, Deakin University, Burwood, Victoria, Australia., Yates LM; Department for Clinical Genetics, Northern Genetics Service, Newcastle, UK., Bromley RL; Division of Neuroscience, University of Manchester, Manchester, UK.; Royal Manchester Children's Hospital, Manchester University Hospitals NHS Foundation Trust and Manchester Academic Health Sciences Centre, Manchester, UK.
Publikováno v:
Epilepsia [Epilepsia] 2024 Jul; Vol. 65 (7), pp. 2017-2029. Date of Electronic Publication: 2024 May 22.
Autor:
van Rijt-Weetink YRJ; Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, s-Hertogenbosch, The Netherlands.; Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands., Egberts TCG; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands., van Hunsel FPAM; Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, s-Hertogenbosch, The Netherlands.; Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands., Lewis DJ; Global Drug Development, Novartis Pharma GmbH, Wehr, Germany.; School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK., Yates LM; University of Kwazulu-Natal, KRISP, Durban, South Africa.; Northern Genetics Service, Newcastle-upon-Tyne, UK., Winterfeld U; Swiss Teratogen Information Service and Clinical Pharmacology Service, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland., van Puijenbroek EP; Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, s-Hertogenbosch, The Netherlands. e.vanpuijenbroek@lareb.nl.; Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands. e.vanpuijenbroek@lareb.nl.
Publikováno v:
Drug safety [Drug Saf] 2024 Mar; Vol. 47 (3), pp. 261-270. Date of Electronic Publication: 2024 Jan 06.
Autor:
Favre G; Swiss Teratology Information Service and Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Materno-fetal and Obstetrics Research Unit, Department 'Femme-Mère-Enfant', Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Richardson JL; UK Teratology Information Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.; Institute of Health and Society, Newcastle upon Tyne, UK., Moore A; Novartis Pharma AG, Basel, Switzerland., Geissbühler Y; Novartis Pharma AG, Basel, Switzerland., Jehl V; Novartis Pharma AG, Basel, Switzerland., Oliver A; UK Teratology Information Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Shechtman S; The Israeli Teratology Information Service, Ministry of Health, Jerusalem, Israel., Diav-Citrin O; The Israeli Teratology Information Service, Ministry of Health, Jerusalem, Israel., Berlin M; Clinical Pharmacology and Toxicology Unit, Drug Consultation Center, Shamir Medical Center (Assaf Harofeh), Affiliated with the Sackler Faculty of Medicine, Zerifin TIS, Tel Aviv University, Tel Aviv, Israel., De Haan T; Clinical Pharmacology and Toxicology Unit, Drug Consultation Center, Shamir Medical Center (Assaf Harofeh), Affiliated with the Sackler Faculty of Medicine, Zerifin TIS, Tel Aviv University, Tel Aviv, Israel., Baud D; Materno-fetal and Obstetrics Research Unit, Department 'Femme-Mère-Enfant', Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Panchaud A; Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.; Service of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Mor A; Epidemiology and Benefit Risk, Sanofi, North York, ON, Canada., Sabidó M; Merck Healthcare KGaA, Darmstadt, Germany., de Souza S; Merck Healthcare KGaA, Darmstadt, Germany., Chambers C; Organization of Teratology Information Specialists (OTIS), University of California San Diego, San Diego, CA, USA., van Rijt-Weetink YRJ; Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands., van Puijenbroek EP; Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands., Yates LM; Northern Genetics Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.; KRISP, University of KwaZulu-Natal, KwaZulu-Natal, South Africa., Girardin F; Swiss Teratology Information Service and Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Stellfeld M; Novo Nordisk A/S, Søborg, Denmark., Winterfeld U; Swiss Teratology Information Service and Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. ursula.winterfeld@chuv.ch.
Publikováno v:
Drug safety [Drug Saf] 2024 Mar; Vol. 47 (3), pp. 227-236. Date of Electronic Publication: 2023 Dec 19.